Does statin suppress oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer? A single-center observational study

被引:0
作者
Kazuaki Okamoto
Hiroaki Nozawa
Shigenobu Emoto
Koji Murono
Kazuhito Sasaki
Soichiro Ishihara
机构
[1] The University of Tokyo,Department of Surgical Oncology
来源
Supportive Care in Cancer | 2023年 / 31卷
关键词
Colorectal cancer; Statins; Neuropathy; Oxaliplatin; Adjuvant chemotherapy; CAPOX;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 111 条
[1]  
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]  
Ferlay J(2019)Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors Prz Gastroenterol 14 89-103
[3]  
Soerjomataram I(1989)Surgical adjuvant therapy of largebowel carcinoma : an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic J Clin Oncol 7 1447-1456
[4]  
Rawla P(1990)Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma N Engl J Med 322 352-358
[5]  
Sunkara T(1995)Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma : a final report Ann Intern Med 122 321-326
[6]  
Barsouk A(2004)Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2343-2351
[7]  
Laurie JA(2015)Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial J Clin Oncol 33 3733-3740
[8]  
Moertel CG(2007)Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07 J Clin Oncol 25 2198-2204
[9]  
Fleming TR(2017)Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer PLoS One 12 e0176745-3116
[10]  
Moertel CG(2009)Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adju-vant treatment in stage II or III colon cancer in the MOSAIC trial J Clin Oncol 27 3109-20